跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX ASPEN 100 MG/ML SOLUCIÓN INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX ASPEN 100 MG/ML SOLUCIÓN INYECTABLE EFG
Approved
STANDARD
SUGAMMADEX ASPEN 100 MG/ML SOLUCIÓN INYECTABLE EFG
Aspen Pharma Trading Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 15, 2023
Approval ID
c748e9fa6eceb969
Company
Aspen Pharma Trading Limited
Type
Standard
Approval Details
Approval Id
c748e9fa6eceb969
Drug Cima Aemps Name
SUGAMMADEX ASPEN 100 MG/ML SOLUCIÓN INYECTABLE EFG
Register Number
88555
Holder Company Name
Aspen Pharma Trading Limited
Marketing Company Name
Aspen Pharmacare Espana S.L.
Holder Company Detail Path
/organization/aspen-pharma-trading-limited
Authorization Date
2023-03-15
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Aspen Pharma Trading Limited
Company Detail Path
/organization/aspen-pharma-trading-limited
Company Information
Pharmaceutical Company Name
ASPEN PHARMA TRADING LIMITED
Country Name
Ireland
City Name
saggart,country_ie
Address
3016 Lake Drive
Active Ingredients
SUGAMMADEX SODIO
108,8 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 15, 2023
Approval ID
c748e9fa6eceb969
Type
Standard
Back to CIMA-AEMPS Approvals
